ArticleLeukemia research reports2025

Selinexor combination with decitabine and half-dose CMG (Cytarabine+ Mitoxantrone+G-CSF) in Patients with refractory/relapsed acute myeloid leukemia (AML) previously exposed to Venetoclax: a single-center retrospective study.

Zi-Yu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.